Clinical Trial Update: A Study to Evaluate Rivoceranib Plus Best Supportive Care Compared to Placebo Plus Best Supportive Care in Participants With Gastric Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating rivoceranib plus best supportive care versus placebo plus best supportive care in gastric cancer; trial completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer

Drugs mentioned

• Rivoceranib (rivoceranib)

Snippet

Sponsor: Elevar Therapeutics | Conditions: Gastric Cancer, Gastric Adenocarcinoma | Phase 3 | Status: COMPLETED | Results posted: 2022-07-08